Clinical Trial Update: Health Economic Evaluation of Primovist-enhanced Liver MRI [Phase 4]

View source ↗

Summary

Phase 4 health economic evaluation of Primovist-enhanced liver MRI for detecting hepatic metastases in colorectal cancer patients; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Neoplasm Metastasis

Drugs mentioned

• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Bayer | Conditions: Colorectal Neoplasms, Neoplasm Metastasis | Phase 4 | Status: COMPLETED